XML 36 R21.htm IDEA: XBRL DOCUMENT
v3.24.2

Revenue Recognition (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Revenue Recognition [Abstract] |
Schedule of Disaggregated Revenue |
Net Sales by Business |  |  |  |  |  |  |
| Three Months |  | Six Months
| 2024 |  | 2023 |  | 2024 |  | 2023
MedSurg and Neurotechnology: |  |  |  |  |  |  |
Instruments | $ | 698 |  |  | $ | 622 |  |  | $ | 1,365 |  |  | $ | 1,188 |
Endoscopy | 768 |  |  | 713 |  |  | 1,546 |  |  | 1,420 |
Medical | 908 |  |  | 841 |  |  | 1,772 |  |  | 1,619 |
Neurovascular | 327 |  |  | 311 |  |  | 637 |  |  | 595 |
Neuro Cranial | 416 |  |  | 373 |  |  | 796 |  |  | 728 |
| $ | 3,117 |  |  | $ | 2,860 |  |  | $ | 6,116 |  |  | $ | 5,550 |
Orthopaedics and Spine: |  |  |  |  |  |  |
Knees | $ | 602 |  |  | $ | 562 |  |  | $ | 1,190 |  |  | $ | 1,128 |
Hips | 428 |  |  | 393 |  |  | 821 |  |  | 768 |
Trauma and Extremities | 832 |  |  | 766 |  |  | 1,662 |  |  | 1,535 |
Spine | 307 |  |  | 296 |  |  | 607 |  |  | 580 |
Other | 136 |  |  | 119 |  |  | 269 |  |  | 213 |
| $ | 2,305 |  |  | $ | 2,136 |  |  | $ | 4,549 |  |  | $ | 4,224 |
Total | $ | 5,422 |  |  | $ | 4,996 |  |  | $ | 10,665 |  |  | $ | 9,774 |
Net Sales by Geography |  |  |  |  |
| Three Months 2024 |  | Three Months 2023
| United States | International |  | United States | International
MedSurg and Neurotechnology: |  |  |  |  |
Instruments | $ | 564 |  | $ | 134 |  |  | $ | 504 |  | $ | 118 |
Endoscopy | 623 |  | 145 |  |  | 576 |  | 137 |
Medical | 763 |  | 145 |  |  | 682 |  | 159 |
Neurovascular | 127 |  | 200 |  |  | 123 |  | 188 |
Neuro Cranial | 339 |  | 77 |  |  | 306 |  | 67 |
| $ | 2,416 |  | $ | 701 |  |  | $ | 2,191 |  | $ | 669 |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 433 |  | $ | 169 |  |  | $ | 406 |  | $ | 156 |
Hips | 261 |  | 167 |  |  | 249 |  | 144 |
Trauma and Extremities | 610 |  | 222 |  |  | 559 |  | 207 |
Spine | 229 |  | 78 |  |  | 221 |  | 75 |
Other | 98 |  | 38 |  |  | 85 |  | 34 |
| $ | 1,631 |  | $ | 674 |  |  | $ | 1,520 |  | $ | 616 |
Total | $ | 4,047 |  | $ | 1,375 |  |  | $ | 3,711 |  | $ | 1,285 |
Net Sales by Geography |  |  |  |  |
| Six Months 2024 |  | Six Months 2023
| United States | International |  | United States | International
MedSurg and Neurotechnology: |  |  |  |  |
Instruments | $ | 1,096 |  | $ | 269 |  |  | $ | 945 |  | $ | 243 |
Endoscopy | 1,259 |  | 287 |  |  | 1,149 |  | 271 |
Medical | 1,478 |  | 294 |  |  | 1,294 |  | 325 |
Neurovascular | 248 |  | 389 |  |  | 241 |  | 354 |
Neuro Cranial | 648 |  | 148 |  |  | 595 |  | 133 |
| $ | 4,729 |  | $ | 1,387 |  |  | $ | 4,224 |  | $ | 1,326 |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 862 |  | $ | 328 |  |  | $ | 822 |  | $ | 306 |
Hips | 512 |  | 309 |  |  | 485 |  | 283 |
Trauma and Extremities | 1,221 |  | 441 |  |  | 1,113 |  | 422 |
Spine | 450 |  | 157 |  |  | 433 |  | 147 |
Other | 187 |  | 82 |  |  | 146 |  | 67 |
| $ | 3,232 |  | $ | 1,317 |  |  | $ | 2,999 |  | $ | 1,225 |
Total | $ | 7,961 |  | $ | 2,704 |  |  | $ | 7,223 |  | $ | 2,551 |
Contract with Customer, Contract Asset, Contract Liability, and Receivable | Changes in contract liabilities during the six months 2024 were as follows:
| June 30
| 2024
Beginning contract liabilities | $ | 860 |
Revenue recognized from beginning of year contract liabilities | (268) |
Net advance consideration received during the period | 329 |
Ending contract liabilities | $ | 921 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration